[This review was originally posted at the Nieman Journalism Lab Order Diflucan, on February 10, 2012.]
Is Facebook a threat to the open web?: There was still a lot of smart commentary on Facebook's filing for a public stock offering rolling in last late week, so I'll start with a couple pieces I missed in last week's review: Both the Atlantic's Alexis Madrigal and Slate's Farhad Manjoo were skeptical of Facebook's ability to stay so financially successful. Madrigal said it's going to have to get a lot more than the $4.39 in revenue per user it's currently getting, and Manjoo wondered about what happens after the social gaming craze that's been providing so much of Facebook's revenue passes.
How to supplement those revenue streams. A lot of the answer's going to come from personal data aggregation, and law professor Lori Andrews wrote in the New York Times about some of the dark sides of that practice, Diflucan over the counter, including stereotyping and discrimination. Facebook also needs to move more deeply into mobile, and Wired's Tim Carmody documented its struggles in that area. On the bright side, Wired's Steven Levy approved of Mark Zuckerberg's letter to shareholders and his articulation of The Hacker Way, Order Diflucan.
Facebook's filing also spurred an intriguing discussion of the relationship between it, Google, and the open web. As web pioneer John Battelle said best and the Atlantic's James Fallows summarized aptly, Diflucan long term, several observers were concerned that Facebook's rise and Google's potential decline is a loss for the open web, because Google built its financial success on the success of the open web while Facebook's success depends on increased sharing inside its own private channels. As Battelle argued, this private orientation threatens the core values that should drive the Internet: decentralization, a commons-based ethos, Canada, mexico, india, neutrality, interoperability, and data openness. Mathew Ingram of GigaOM countered that users don't care so much about openness as usefulness, and that's what could eventually do Facebook in.
Another Facebook-related discussion sprung up around Evgeny Morozov's piece for the New York Times lamenting the death of cyberflânerie — the practice of strolling through the streets of the web alone, taking in and reflecting on its sights and sounds. Order Diflucan, Among other factors, he pinpointed Facebook's "frictionless sharing" as the culprit, by mandating that all experiences be shared and tailored to our narrow interests. Sociologist Zeynep Tufekci pushed back against Morozov's argument, buy Diflucan without a prescription, countering that there's still plenty of room for sharing-based serendipity because our friends' interests don't exactly line up with our own. And journalist Dana Goldstein argued that a lot of what yesterday's flâneurs did is still echoed in the web today, for better or worse — cyberstalking, trying out new identities, and presenting our ideal selves to the public. Discount Diflucan, —
The clampdown on breaking news via Twitter: One of international journalism's leaders in social media innovation, News Corp.'s Sky News, issued a surprisingly stern crackdown on its journalists' Twitter practices, Banning them from retweeting information from any other journalists without clearing it past the news desk and from tweeting about anything outside their beats.
The were a few people in favor of the new policy — Forbes' Ewan Spence applauded the 'better right than first' approach, and Fleet Street Blues rather headscratchingly asserted that " it makes no sense for them to pay journalists to report through a medium outside its own editorial controls." But far more people were crying out in opposition.
Reuters' Anthony De Rosa reiterated that argument that a retweet is simply a quote, rather than an endorsement, and Breaking News' Cory Bergman said not all the broadcast rules apply to Twitter — it's OK to be human there, Order Diflucan. GigaOM's Mathew Ingram and POLIS' Charlie Beckett made the point that Sky should want its reporters to be seen as go-to information sources, buy Diflucan from canada, period — no matter where the information comes from. As Beckett put it: "We the audience now privilege interactivity and added value over conformity. We trust you because you share, not because you have hierarchical structures."
The BBC also updated its social media guidelines to urge reporters not to break news on Twitter before they file it to the BBC's internal systems. BBC social media editor Chris Hamilton quickly clarified that the policy wasn't as restrictive as it sounded: The BBC's tech allows its journalists to file simultaneously to Twitter and to its newsroom CMS (an impressive feat in itself), Fast shipping Diflucan, and when that tech isn't available, they want their journalists to file to the newsroom first — "a difference of a few seconds."
J-prof Alfred Hermida said the idea that journalists shouldn't break news on Twitter rests on the flawed assumption that journalists have a monopoly on breaking the news. Order Diflucan, And on Twitter, fellow media prof C.W. Anderson asserted that the chief problem lies in the idea that breaking news adds significant value to a story. "The debate over "breaking news on Twitter" is a perfect example of mistaking professional values for public / financial / "rational" ones," he wrote.
An unclear picture of the Times' paywall: The New York Times released its fourth-quarter results late last week, and, purchase Diflucan online, as usual with their recent announcements, it proved something of a media business Rorschach test. The company reported a loss of $39.7 million for the year, thanks in large part to declines in advertising revenue — though most of that was due to About.com, as revenue in its news division was slightly up for the quarter.
As for the paywall, the Times reported 324,000 digital subscribers, with a total of 390,000 once you added in the International Herald Tribune, Order Diflucan. Diflucan used for, Media analyst Ken Doctor estimated the Times' paywall revenue at $86 million and said the paper has climbed a big mountain in getting more than 70% of its print subscribers to sign up for online access. Reuters' Felix Salmon saw the paywall numbers as "unamiguously good news" and said it shows the paywall hasn't eaten into ad revenues as much as it was expected to.
Others were a bit less optimistic. GigaOM's Mathew Ingram said the Times' new paywall revenue still isn't enough to make up for its ad revenue declines, and urged the times to go beyond the paywall in hunting for digital revenue. Media analyst Greg Satell made a similar point Order Diflucan, , arguing that the paywall is a false hope and calling for the Times build up more "satellite" brands online, like the Wall Street Journal's All Things Digital. Henry Blodget of Business Insider had a different solution: Keep cutting costs until the newsroom is down to a size that can be supported by a digital operation.
A nonprofit journalism merger: After a few weeks of speculation, kjøpe Diflucan på nett, köpa Diflucan online, two of the U.S.' more prominent nonprofit news operations, the Bay Citizen and the Center for Investigative Reporting, have announced their intent to merge. Both groups are based in California's Bay Area, and the CIR runs the statewide news org California Watch. Diflucan from mexico, The executive director of the new organization would be Phil Bronstein, the CIR board chairman and former San Francisco Chronicle editor.
Opinions on the move were mixed: Oakland Local founder (and former California Watch consultant) Susan Mernit thought it would make a lot of sense, combining the Bay Citizen's strengths in funding and distribution with California Watch's strengths in editorial content, Order Diflucan. Likewise, the Lab's Ken Doctor saw it as an opportunity to make local nonprofit journalism work at an unprecedented scale.
There are reasons for caution, though. As Jim Romenesko noted, buy cheap Diflucan, the Bay Citizen has recently gone through several key departures and the unexpected death of its co-founder and main benefactor, Warren Hellman (and even forgot to renew its web domain for a bit). And California Watch pointed out some of the potential conflicts between the two newsrooms — California Watch has a partnership with the Chronicle, whom the Bay Citizen considers a competitor. Order Diflucan, And the Bay Citizen has its own partnership with the New York Times for its regional edition, something PBS MediaShift's Ashwin Seshagiri said could now prove as much a hindrance as an advantage.
J-prof Jay Rosen said the two orgs aren't a good fit because of their differing institutional bases — the CIR is more established and has been on a steady build, Real brand Diflucan online, while the Bay Citizen's short history is full of turmoil. And the San Francisco Bay Guardian's Steven Jones argued that Bronstein's rationale for the merger is misrepresenting Hellman's wishes.
Reading roundup: Lots of other stuff going on this week, too. Here's a quick rundown:
— Another week, another few new angles to the already enormous News Corp. phone hacking scandal: The FBI is investigating the company for illegal payments of as much 100,000 pounds to foreign officials such as police officers, a political blogger told British officials that the Sunday Mirror's top editor personally authorized hacking, and the Times of London admitted it hacked into a police officer's email to out him as the author of an anonymous blog, Order Diflucan. How much is this whole mess costing News Corp.? $87 million for the investigation alone last quarter, order Diflucan from United States pharmacy.
— News Corp.'s tablet news publication The Daily got the one-year treatment with an update on its so-so progress in the New York Times. News business analyst Alan Mutter also gave a pretty rough review of the status of tablet news apps as a whole.
— A couple of other news developments of interest to folks in our little niche: The tech news site GigaOM announced it was buying paidContent from the Guardian, and the Knight Foundation announced the first of its new News Challenge competitions, this one oriented around networks. Buy Diflucan online cod, — A couple of cool studies released this week: One from HP Labs on predicting the spread of news on Twitter, and another from USC on ways in which the Internet is changing us.
— Finally, for those of us among the digitally hyper-connected, the New York Times' David Carr wrote a poignant piece on the enduring value of in-person connections, and sociologist Zeynep Tufekci offered a thoughtful response.
Similar posts: Order Armour. Glucophage Dosage. Lipitor Mg. Effects of Lipitor. Where can i order Retin A without prescription. Flagyl photos.
Trackbacks from: Order Diflucan. Order Diflucan. Order Diflucan. Diflucan description. Is Diflucan addictive. Buy Diflucan online no prescription.
[This review was initially posted at the Nieman Journalism Lab Order Bactrim, on January 13, 2012.]
Social search and competition: Google made a major move toward unifying search and social networks (particularly its own) this week by fusing Google+ into its search and deepening its search personalization based on social information. It's a significant development with a lot of different angles, so I'll try to hit all of them as understandably as I can.
As usual, Search Engine Land's Danny Sullivan put together the best basic guide to the changes, with plenty of visual examples and some brief thoughts on many of the issues I'll cover here. TechCrunch's Jason Kincaid explained that while these changes may seem incremental now, low dose Bactrim, they're foreshadowing Google's eventual goal to become "a search engine for all of your stuff."
PaidContent's Jeff Roberts liked the form and functionality of the new search, but said it still needs a critical mass of Google+ activity to become truly useful, while GigaOM's Janko Roettgers said its keys will be photos and celebrities. ReadWriteWeb's Jon Mitchell was impressed by the non-evilness of it, particularly the ability to turn it off. Farhad Manjoo of Slate said Google's reliance on social information is breaking what was a good search engine, Order Bactrim. Comprar en línea Bactrim, comprar Bactrim baratos, Of course, the move was also quite obviously a shot in the war between Google and Facebook (and Twitter, as we'll see later): As Ars Technica's Sean Gallagher noted, Google wants to one-up Facebook's growing social search and keep some of its own search traffic out of Facebook. Ben Parr said Facebook doesn't need to worry, though Google has set up Google+ as the alternative if Facebook shoots itself in the foot.
But turning a supposedly neutral search engine into a competitive weapon didn't go over well with a lot of observers, generic Bactrim. The Atlantic's Alexis Madrigal saw a conflict between Google's original mission (organizing the world's information) and its new social mission, and Danny Sullivan said Google is putting score-settling above relevance. Several others sounded similar alarms: Mathew Ingram of GigaOM said users are becoming collateral damage Order Bactrim, in the war between the social networks, and web veteran John Battelle argued that the war was bad for Google, Facebook, and all of us on the web. "The unwillingness of Facebook and Google to share a public commons when it comes to the intersection of search and social is corrosive to the connective tissue of our shared culture," he wrote.
For others, the changes even called up the specter of antitrust violations. MG Siegler said he doesn't mind Google's search (near-) monopoly, but when it starts using that monopoly to push its other products, Bactrim no rx, that's when it turns into a legal problem. Danny Sullivan laid out some of the areas of dispute in a possible antitrust case and urged Google to more fully integrate its competitors into search.
Twitter was the first competitor to voice its displeasure publicly, releasing a statement arguing that deprioritizing Twitter damages real-time search. (TechCrunch has the statement and some valuable context.) Google responded by essentially saying, "Hey, you dumped us, Bactrim pictures, buddy," and its executive chairman, Eric Schmidt, told Search Engine Land they'd be willing to negotiate with Twitter and Facebook.
Finally, some brief journalistic implications: Poynter's Jeff Sonderman said this means SEO's value is waning for news organizations, being replaced by the growing importance of building strong social followings and making content easy to share, and Mathew Ingram echoed that idea, Order Bactrim. Daniel Victor of ProPublica had some wise thoughts on the meaning of stronger search for social networks, Bactrim reviews, concluding that "the key is creating strategies that don’t depend on specific tools. Don’t plan for more followers and retweets; plan for creating incentives that will gather the most significant contributions possible from non-staffers."
Innovation and its discontents: Washington Post ombudsman Patrick Pexton inducing a bit of eye-rolling among digital media folks this week with a column arguing that the paper is "innovating too fast" by overwhelming readers and exhausting employees with a myriad of initiatives that lack a coherent overall strategy. J-prof Jay Rosen followed up with a revealing chat with Pexton that helps push the discussion outside of the realm of stereotypes: Pexton isn't reflexively defending the status quo (though he remains largely print-centric), but thinks there are simply too many projects being undertaken without an overarching philosophy about how or why things should be done.
Pexton got plenty of push-back, not least from the Post's own top digital editor, Raju Narisetti, who responded by essentially saying, where can i buy cheapest Bactrim online, in Rosen's paraphrase, "This is the way it’s going to be and has to be, if the Post is to survive and thrive. It may well be exhausting but there is no alternative." GigaOM's Mathew Ingram said he was just about to praise the Post for its bold experimentation, and the Guardian's Martin Belam argued that Pexton is actually critiquing newness, Online buying Bactrim, rather than innovation.
J-prof Alfred Hermida argued Order Bactrim, — as Pexton himself seemed to in his chat with Rosen — that the issue is not about how fast or slow innovation is undertaken, but whether that innovation is done in a way that's good or bad for journalism. Former Sacramento Bee editor Melanie Sill responded that many newspapers remain stuck in 20th-century formulas, blinding them to the fact that what they consider revolutionary change is only a minor, outmoded shift. She noted that all the former top editors she's talked to have had the same regret: that they hadn't pushed harder for change. And Free Press' Josh Stearns pointed out that we should expect the path toward that change to be an easy one.
'Truth vigilantes' and objectivity: Pexton wasn't the only ombudsman this week to be put on the defensive after a widely derided column: New York Times public editor Arthur Brisbane drew plenty of criticism yesterday when he asked whether Times reporters should call out officials' untruths in their stories — or, as he put it, where to buy Bactrim, act as a "truth vigilante." Much of the initial reaction was a variation of, "How is this even a question?"
Brisbane told Romenesko that he wasn't asking whether the Times should fact-check statements and print the truth, but whether reporters should "always rebut dubious facts in the body of the stories they are writing." He reiterated this in a follow-up, in which he also printed a response by Times executive editor Jill Abramson saying the Times does this all the time. Her point was echoed by former Times executive editor Bill Keller and PolitiFact editor Bill Adair, Buy Bactrim from mexico, and while he called the initial question "stupid," Reuters' Jack Shafer pointed out that Brisbane isn't opposed to skepticism and fact-checking.
The American Journalism Review's Rem Rieder enthusiastically offered a case for a more rigorous fact-checking role for the press, as did the Online Journalism Review's Robert Niles (though his enthusiasm was with tongue lodged in cheek), Order Bactrim. The Atlantic's Adam Clark Estes used the episode as an opportunity to explain how deeply objectivity is ingrained in the mindset of the American press, pointing to the "view from nowhere" concept explicated by j-prof Jay Rosen. Rosen also wrote about the issue himself, arguing that objectivity's view from nowhere has surpassed truthtelling as a priority among the press.
How useful is the political press?: The U.S, buy Bactrim online no prescription. presidential primary season is usually also peak political-journalism-bashing season, but there were a couple of pieces that stood out this week for those interested in the future of that field. The Washington Post's Dana Milbank mocked Order Bactrim, the particular pointlessness of this campaign's reporting, describing scenes of reporters vastly outnumbering locals at campaign events and remarking, "if editors knew how little journalism occurs on the campaign trail, they would never pay our expenses."
The New Yorker's John Cassidy defended the political press against the heat it's been taking, arguing that it still produces strong investigative and long-form reporting on important issues, and that the speed of the new news cycle allows it to correct itself quickly. He blamed many of its perceived failings not on the journalists themselves, but on the public that's consuming their work.
The Boston Phoenix reported on the decline of local newspapers' campaign coverage and wondered if political blogs and websites could pick up the slack, Bactrim use, while the Lab's Justin Ellis looked at why news orgs love partnering up during campaign season, focusing specifically on the newly announced NBC News-Newsweek/Daily Beast arrangement.
A unique paywall model: The many American, British, and Canadian publishers implementing or considering paywalls might marvel at the paid-content success of Piano Media, but they can't hope to emulate it: A year after gaining the cooperation of each of Slovakia's major news publishers for a unified paywall there, the company is expanding the concept to Slovenia, no prescription Bactrim online. As paidContent noted, Piano is hoping to sign up 1% of Slovenia's Internet-using population, and the Lab's Andrew Phelps reported that the company is planning to bring national paywalls to five European nations by the end of the year. As Piano's CEO told Phelps, the primary barrier to subscription has not been economic, but philosophical, especially for commenting, Order Bactrim.
Elsewhere in paywalls, media consultant Frederic Filloux looked at what's making the New York Times' strategy work so far — unique content, Bactrim results, a porous paywall that allows it to maintain high traffic numbers and visibility, and cooperation with Apple — and analyst Ken Doctor wondered whether all-access subscriptions across multiple devices and publications within a company could be a key to paid content this year.
Reading roundup: Tons of smaller stuff going on this week outside the glare of the Google-Facebook-Twitter wars. Here's a quick rundown:
— One item I forgot to note from late last week: The AP and a group of 28 other news organizations have launched NewsRight, a system to help news orgs license their content to online aggregators. Poynter's Rick Edmonds offered a detailed analysis, but GigaOM's Mathew Ingram was skeptical, Bactrim steet value.
— The online commenting service Disqus released some of its internal research Order Bactrim, showing that pseudonymous commenters tend to leave more and higher-quality comments than their real-name counterparts. GigaOM's Mathew Ingram used the data to argue that a lack of real names isn't nearly as bad as its critics say.
— No real news in SOPA this week, but the text of Cory Doctorow's lecture last month on SOPA and the dangers of copyright regulation has been posted. It's long, but worth a read.
— Finally, three fantastic practical posts on how to practice digital journalism, from big-picture to small-grain: Howard Owens of the Batavian's list of things journalists can do to reinvent journalism, Melanie Sill at Poynter on how to begin doing open journalism, and Steve Buttry of the Journal Register Co. on approaching statehouse coverage from a digital-first perspective.
Similar posts: Armour Cost. Buy Tramadol No Prescription. Order Flagyl. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Order Bactrim. Order Bactrim. Order Bactrim. Order Bactrim no prescription. Buy Bactrim from mexico. Bactrim maximum dosage.
[This review was originally posted at the Nieman Journalism Lab Retin A Over The Counter, on January 6, 2012.]
Murdoch, Twitter, and identity: News Corp.'s Rupert Murdoch had a pretty horrible 2011, but he ended it with a curious decision, joining Twitter on New Year's Eve. The account was quickly verified and introduced as real by Twitter Chairman Jack Dorsey, dousing some of the skepticism about its legitimacy. His Twitter stream so far has consisted of a strange mix of News Corp. promotion and seemingly unfiltered personal opinions: He voiced his support for presidential candidate Rick Santorum (a former paid analyst for News Corp.'s Fox News), and ripping former Fox News host Glenn Beck. Cheap Retin A, But the biggest development in Murdoch's Twitter immersion was about his wife, Wendi Deng, who appeared to join Twitter a day after he did and was also quickly verified as legitimate by Twitter. (The account even urged Murdoch to delete a tweet, which he did.) As it turned out, though, the account was not actually Deng, but a fake run by a British man, Retin A Over The Counter. He said Twitter verified the account without contacting him.
This, understandably, raised a few questions about the reliability of identity online: If we couldn't trust Twitter to tell us who on its service was who they said they were, Retin A price, the issue of online identity was about to become even more thorny. GigaOM's Mathew Ingram chastised Twitter for its lack of transparency about the process, and the Washington Post's Erik Wemple urged Twitter to get out of the verification business altogether: "The notion of a central authority — the Twitterburo, so to speak — sitting in judgment of authentic identities grinds against the identity of Twitter to begin with." (Twitter has begun phasing out verification, limiting it to a case-by-case basis.)
Eric Deggans of the Tampa Bay Times argued that the whole episode proved that regardless of what Twitter chooses to do, Retin A natural, "the Internet is always the ultimate verification system for much of what appears on it." Kara Swisher of All Things Digital unearthed the problem in this particular case that led to the faulty verification: A punctuation mixup in communication with Deng's assistant.
Columbia's Emily Bell drew a valuable lesson from the Rupert-joins-Twitter episode: As they wade into the social web, news organizations, she argued, need to do some serious thinking about how much control they're giving up to third-party groups who may not have journalism among their primary interests. Retin A Over The Counter, Elsewhere in Twitter, NPR Twitter savant Andy Carvin and NYU prof Clay Shirky spent an hour on WBUR's On Point discussing Twitter's impact on the world.
Trend-spotting for 2011 and 2012: I caught the front end of year-in-review season in my last review before the holidays, after the Lab's deluge of 2012 predictions, buy generic Retin A. But 2011 reviews and 2012 previews kept rolling in over the past two weeks, giving us a pretty thoroughly drawn picture of the year that was and the year to come. We'll start with 2011.
Nielsen released its list of the most-visited sites and most-used devices of the year, with familiar names — Google, Order Retin A from mexican pharmacy, Facebook, Apple, YouTube — at the top. And Pew tallied the most-talked-about subjects on social media: Osama bin Laden on Facebook and Egypt's Hosni Mubarak on Twitter topped the lists, and Pew noted that many of the top topics were oriented around specific people and led by the traditional media, Retin A Over The Counter.
The Next Web's Anna Heim and Mashable's Meghan Peters reviewed the year in digital media trends, touching on social sharing, personal branding, paywalls, buying Retin A online over the counter, and longform sharing, among other ideas. At PBS MediaShift, Jeff Hermes and Andy Sellars authored one of the most interesting and informative year-end media reviews, looking at an eventful year in media law. Retin A street price, As media analyst Alan Mutterpointed out, though, 2011 wasn't so great for newspapers: Their shares dropped 27% on the year.
One of the flashpoints in this discussion of 2011 was the role of paywalls in the development of news last year: Mashable's Peters called it "the year the paywall worked," and J-Source's Belinda Alzner said the initial signs of success for paywalls are great news for the financial future of serious journalism. Mathew Ingram of GigaOM pushed back Retin A Over The Counter, against those assertions, arguing that paywalls are only working in specific situations, and media prof Clay Shirky reflected on the ways paywalls are leading news orgs to focus on their most dedicated users, which may not necessarily be a bad thing. "The most promising experiment in user support means forgoing mass in favor of passion; this may be the year where we see how papers figure out how to reward the people most committed to their long-term survival," he wrote, online buying Retin A hcl.
Which leads us to 2012, and sets of media/tech predictions from the Guardian's Dan Gillmor, j-prof Alfred Hermida, Mediaite's Rachel Sklar, Poynter's Jeff Sonderman, Taking Retin A, and Sulia's Joshua Young. Sklar and Sonderman both asserted that news is going to move the needle online (especially on Facebook, according to Sonderman), and while Hermida said social media is going to start to just become part of the background, he argued that that's a good thing — we're going to start to find the really interesting uses for it, as Gillmor also said. J-prof Adam Glenn also chimed in at PBS MediaShift with his review of six trends in journalism education, where can i cheapest Retin A online, including journo-programming and increased involvement in community news.
SOPA's generation gap: The debate over Internet censorship and SOPA will continue unabated into the new year, and we're continuing to see groups standing up for and against the bill, with the Online News Association and dozens of major Internet companiesvoicing their opposition, Retin A Over The Counter. One web company who notoriously came out in favor of the bill, GoDaddy, faced the wrath of the rest of the web, with some 37, Online buying Retin A hcl, 000 domains being pulled in two days. The web hosting company quickly pulled its support for SOPA, though it isn't opposing the bill, either.
New York Times media critic David Carr also made the case against the bill, noting that it's gaining support because many members of Congress are on the other side of a cultural/generational divide from those on the web. He quoted Kickstarter co-founder Yancey Strickler: "It’s people who grew up on the Web versus people who still don’t use it, Retin A online cod. Retin A Over The Counter, In Washington, they simply don’t see the way that the Web has completely reconfigured society across classes, education and race. The Internet isn’t real to them yet."
Forbes' Paul Tassi wrote about the fact that many major traditional media companies have slyly promoted some forms of piracy over the past decade, and GigaOM's Derrick Harris highlighted an idea to have those companies put some of their own money into piracy enforcement.
Tough times for the Times: It's been a rough couple of weeks for the New York Times: Hundreds of staffers signed an open letter to Publisher Arthur Sulzberger Jr. expressing their frustration over various compensation and benefits issues. The Huffington Post's Michael Calderone reported that the staffers' union had also considered storming Sulzberger's office or walking out, Taking Retin A, and Politico's Dylan Byers noted that the signers covered a broad swath of the Times' newsroom, cutting across generational lines.
The Atlantic's Adam Clark Estes gave some of the details behind the union's concerns about the inequity of the paper's buyouts, Retin A Over The Counter. But media consultant Terry Heaton didn't have much sympathy: He said the union's pleas represented an outmoded faith in the collective, and that Times staffers need to take more of an everyone-for-themselves approach.
The Times also announced it would sell its 16 regional newspapers for $143 million to Halifax Media Group, a deal that had been rumored for a week or two, and told Jim Romenesko it would drop most of its podcasts this year, online buy Retin A without a prescription. To make matters worse, the paper mistakenly sent an email to more than 8 million followers telling them their print subscriptions had been canceled.
Reading roundup: Here's what else you might have missed over the holidays:
— A few thoughtful postscripts in the debate over PolitiFact and fact-checking operations: Slate's Dave Weigel and Forbes' John McQuaid dissected PolitiFact's defense, and Poynter's Craig Silverman offered some ideas for improving fact-checking from a recent roundtable. And Greg Marx of the Columbia Journalism Review argued that fact-checkers are over-reaching beyond the bounds of the bold language they use. Retin A for sale, — A couple of good pieces on tech and the culture of dissent from Wired: A Sean Captain feature on the efforts to meet the social information needs of the Occupy movement, and the second part of Quinn Norton's series going inside Anonymous.
— For Wikipedia watchers, a good look at where the site is now and how it's trying to survive and thrive from American Prospect.
— Finally, a deep thought about journalism for this weekend: Researcher Nick Diakopoulos' post reconceiving journalism in terms of information science.
Similar posts: Tramadol Over The Counter. Retin A Price. Order Lipitor. Synthroid no rx. Buy Retin A no prescription. Diflucan from canada.
Trackbacks from: Retin A Over The Counter. Retin A Over The Counter. Retin A Over The Counter. Retin A long term. Buy no prescription Retin A online. Ordering Retin A online.
[This review was originally posted at the Nieman Journalism Lab Purchase Flagyl, on Dec. 23, 2011.]
Rethinking political fact-checking: PolitiFact, the fact-checking organization launched in 2007 by the St. Petersburg Times,named its lie of the year this week, Flagyl interactions, and the choice wasn't a popular one: The Democratic claim that Republicans voted to end Medicare was widely denounced among liberal observers (and some conservative ones) as not actually being a lie. As the Washington Monthly's Steve Benen noted, the Medicare claim only finished third in PolitiFact's reader voting behind two Republican lies, leading to the widespread belief, as Benen and the New York Times' Paul Krugman expressed, that PolitiFact chose a Democratic claim this year to create an appearance of balance and placate its conservative critics who believe it's biased against them.
This sort of liberal/conservative bias sniping goes on all the time in political media, canada, mexico, india, but this issue got a bit more interesting from a future-of-news perspective when it became an entree into a discussion of the purpose of the burgeoning genre of "fact-checking" news itself. At Mother Jones, Adam Serwer argued that the reason fact-checking sites exist in the first place is as a correction to the modern sense of news objectivity as a false sense of balance, as opposed to determining the truth — something he said even the fact-checking sites are now succumbing to, Purchase Flagyl.
Several others decried fact-checking operations as being, as Salon's Glenn Greenwald put it, a "scam of neutral expertise." Forbes' John McQuaid said PolitiFact "is trying to referee a fight that, frankly, Flagyl from canadian pharmacy, doesn't really need a referee." Gawker's Jim Newell was more sweeping: "why does anyone care what this gimmicky website has to say, ever?" He argued that fact-checking sites' designations like "pants on fire" and "Pinocchios" are easily digestible gimmicks that lend them a false air of authority, obscuring their flaws in judgment. And the Washington Post's Ezra Klein called the fact-checking model "unsustainable," because it relies on maintaining legitimacy in the eyes of both sides of a hopelessly fractured public.
At The New Republic, Alec MacGillis made the point that fact-checking "invests far too much weight and significance in a handful of arbiters who, Flagyl photos, every once in a while, will really blow a big call." Instead, he said, fact-checking should be the job of every reporter, not just a specialized few. Ordering Flagyl online, Glenn Kessler, the Washington Post's "Fact Checker," responded by saying operations like his aren't intended to be referees or replace reporting, but to complement it. PolitiFact's Bill Adair stood by the organization's choice and said fact-checking "is growing and thriving because people who live outside the partisan bubbles want help sorting out the truth."
An abrupt change at the Times Purchase Flagyl, : New York Times Co. CEO Janet Robinson surprised Times staffers late last week with the sudden announcement of her retirement, and some details have trickled out since then: Reuters reported that she'll get a $15 million exit package and that she and company chairman Arthur Sulzberger Jr. clashed at times, buying Flagyl online over the counter, and the Wall Street Journal reported (paywall) that much of the dissatisfaction with Robinson was over her digital strategy. The Atlantic's Adam Clark Estes summed up the reporting and speculation on Robinson's forced departure by saying that she didn't get along with her bosses, and the Times felt it needed a technologist.
With no successor in sight, GigaOM's Mathew Ingram gave the blueprint of what he would do with the paper: Scale back the paywall, Order Flagyl from mexican pharmacy, and go deeper into apps, events, and e-books. CUNY j-prof Jeff Jarvis proposed a "reverse meter" for the Times — pay up front, then get credit for reading and interacting that delays your next bill. He acknowledged that it wouldn't work in practice, but said it illustrates the idea that paywalls should reward loyal customers, not punish them, Purchase Flagyl. Ingram picked up on the idea and threw out a few more possibilities.
In reality, the Times is in the process of making quite a different set of moves: It's talking about selling off its 16 regional newspapers, not including the Boston Globe, order Flagyl online c.o.d. Media analyst Ken Doctor broke down the development, explaining that the Times Co. is slimming down its peripheral ventures to focus on the Times itself, particularly its digital operation. Poynter's Rick Edmonds said the possible deal marks a thaw Purchase Flagyl, in the newspaper transaction market.
Looking back and forward for news: We're getting into the year-in-review season, Buy Flagyl online no prescription, and Pew's Project for Excellence in Journalism has started it off by releasing its annual analysis of the year's media coverage. They found that this year, just like 2010, was dominated by coverage of the economy, though the Occupy movement emerged as a strong subtheme, and foreign news was a major area of coverage, thanks in large part to the Arab Spring movements, order Flagyl from United States pharmacy. They also examined media coverage in comparison with public interest, finding that journalists moved on from big stories more quickly than the public.
The Lab went big with its year-end feature, publishing more than a dozen predictions for the news world in 2012 from a variety of news and tech luminaries. You can check out that link for the whole list, but here are a few of the trends across the predictions:
— Apps. Nicholas Carr predicted that "appification" would be the dominant force influencing media and news media next year, opening new arenas for paid content, particularly through "versioning." Tim Carmody said e-readers will take a big leap at the same time, led by Amazon's Kindle. Amy Webb predicted the rise of several sophisticated types of apps, and Gina Masullo Chen envisioned our apps leading us into a more personalized news consumption environment, Purchase Flagyl.
— Big institutions make a stand. Flagyl use, It may be in a continued state of decline, as Martin Langeveld predicted, but Dan Kennedy saw the beginnings of a semi-revival for the newspaper business, accompanied by more paywalls and an feistier defense of their value. On a more ominous front, Dan Gillmor warned of tightening content controls by an oligopoly of copyright holders, government forces, Flagyl pictures, search engines, and others.
— Collaboration and curation. Emily Bell saw an increasing realization by news organizations of the importance of networks as part of the reporting process, Burt Herman described the continued emergence of a real-time, collaborative news network, Buy Flagyl from canada, and Paul Bradshaw and Carrie Brown Smith also saw collaboration as central next year. Vadim Lavrusik saw an increasingly sophisticated curation as part of that news environment.
Reading roundup Purchase Flagyl, : This is the last review of the year, so here are the bits and pieces to keep up with during the holidays over the next two weeks:
— Congress' hearings on the Internet censorship bill SOPA adjourned last Friday, with the vote delayed until next year. Cable news finally began acknowledging the story, and the document company Scribd staging an online protest. Techdirt's Mike Masnick continued to write about the bill's dangers, looking at the ability it gives private companies to shut down any website and the way it sets up the legal framework for broader censorship.
— The Wall Street Journal reported on the continued high prices of e-books, a trend that drew criticism from GigaOM's Mathew Ingram and paidContent's Laura Hazard Owen, Flagyl dangers. Elsewhere, Slate's Farhad Manjoo and Wired's Tim Carmody engaged in an interesting discussion about Amazon and independent bookstore — Manjoo praised Amazon for putting independent bookstores into decline, Carmody argued that Amazon has its eyes on a bigger prize, and Manjoo talked about how independent bookstores can fight back.
— A big development in the WikiLeaks and Bradley Manning cases: Wired reported that U.S, Purchase Flagyl. government officials found chat logs with WikiLeaks' Julian Assange on the laptop of Manning, Cheap Flagyl, the Army private charged with leaking information to WikiLeaks. This could be critical in the U.S.' possible prosecution of Assange if the logs show that he induced Manning to leak the documents.
— The Journal Register Co.'s Steve Buttry wrote a series of posts on the practical details of the company's Digital First approach, looking at its journalistic workflow, values, editor's roles, and ways to think like a digital journalist. Meanwhile, Mashable's Lauren Indvik looked at the Atlantic's transformation into a Digital First publication.
— Some great discussion about solution-oriented journalism this week: David Bornstein made a case for solution journalism at the New York Times, and Free Press' Josh Stearns put together a fantastic set of readings on solution journalism. NYU grad student Blair Hickman also shared a syllabus for a solution journalism unit.
Similar posts: Synthroid Over The Counter. Diflucan Cost. Diflucan For Sale. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Purchase Flagyl. Purchase Flagyl. Purchase Flagyl. After Flagyl. Buying Flagyl online over the counter. Ordering Flagyl online.
[This review was originally posted at the Nieman Journalism Lab Cephalexin For Sale, on Nov. 11, 2011.]
Google+ courts businesses: After banning businesses for its first four months, Google+ finally let them in this week, launching Google+ Pages, which gives accounts to business and groups. (Danny Sullivan of Search Engine Land put together the best walkthrough of what Pages are and how they work.) Businesses jumped right in, including, About Cephalexin, of course, news orgs: Breaking News put together a running list of news Pages, and one Fox News show announced it would do Hangouts with presidential candidates, starting with Mitt Romney next week.
As Business Insider explained, Google has a big carrot to draw businesses in: Direct Connect, which allows users to go directly to a business's Google+ Page if they the business's name preceded by a "+". Lost Remote's Cory Bergman (who also runs the Breaking News Google+ account) said businesses should also get some SEO mojo from users clicking +1 on their Google+ account, which he argued was enough of a payoff to justify maintaining a Google+ account — at least for now, Cephalexin over the counter, anyway.
Social media guru Robert Scoble, on the other hand, was disappointed in Pages, calling them clumsy and difficult to manage, Cephalexin For Sale. Fast Company's Mark Wilson brought up the same point and added that since Google gives individuals two options of how to engage with businesses instead of Facebook's single "Like," most people will choose the weaker option. TechCrunch's Jason Kincaid wondered what exactly that weaker option, giving the business a +1, will do.
For Slate's Farhad Manjoo, Doses Cephalexin work, the addition of Pages was too little, too late for Google+. He declared the social network dead, a victim of Google's launch-then-fix-it model that has worked so well for most of its products. "But a social network isn’t a product; it’s a place Cephalexin For Sale, ," Manjoo wrote, arguing that Google should have let its users be more free to experiment to make up for its initial deficits. Mathew Ingram of GigaOM and the New York Times' Nick Bilton countered that it's too soon to give up on the network, because Google+ is designed to be not just another social network, but instead the connective tissue integrating an entire way to experience the web. Google has some pretty good cards still its hand that can help it reach that goal, too, he said.
Romenesko, attribution, and hair-splitting: Jim Romenesko, the dean of media bloggers soon to semi-retire from the Poynter Institute, was pushed into a bizarre little controversy yesterday when his editor, Cephalexin without prescription, Julie Moos, wrote a post taking him to task for "incomplete attribution" in his posts — essentially, using language from the posts he's summarizing (and linking to) without putting it in quote marks. Moos wrote the post in response to questions from the Columbia Journalism Review as it develops an article on the subject.
Romenesko wasn't asked to resign (he offered his resignation twice but Moos rejected it), but he will have to follow stricter attribution guidelines and have his posts edited before they go up. 10, Is Cephalexin addictive, 000 Words' Elena Zak praised Poynter's transparency, but to most observers, this was ethical hairsplitting run amok.
Media consultant Mark Potts hit many of the main points in his defense of Romenesko, noting that no one has complained to Poynter about this in the decade he's been blogging for them. Reuters' Felix Salmon pointed to Romenesko's stature in the blogosphere and his role in establishing the field's norms: "If your guidelines go against what Jim is doing, then there might well be something wrong with your guidelines."
The Awl's Choire Sicha took the opportunity to level a more serious charge at Poynter's handling of Romenesko's blog, saying that "Poynter has worked systematically to erode a fairly noble, not particularly money-making thing as it works to boost 'engagement'" and other online-media buzzwords, Cephalexin For Sale. For his part, Romenesko himself expressed his frustration in typically understated fashion in an email to the New York Times, then tweeted that "I feel it's time to go."
Is future-of-news talk hurting journalism?: This week, we got the rare opportunity to have a substantive, big-picture (meta)discussion about the way we think about the future of news when the Columbia Journalism Review published a thorough critique by Dean Starkman of 'future of news' thinkers like Jeff Jarvis, Clay Shirky, Cephalexin alternatives, and Jay Rosen.
The piece is quite long, but worth a close read: In short, Starkman argued that these thinkers are undermining the most valuable form of journalism — public-service journalism — by disempowering journalists and their institutions and by wasting their limited time (and the public's) with endless, mostly useless experimentation and busywork. Instead, Starkman proposed a model built around maintaining journalism's most valued institutions, Buy Cephalexin without a prescription, arguing that "journalism needs its own institutions for the simple reason that it reports on institutions much larger than itself."
Several people objected to Starkman's argument, starting with media strategist Terry Heaton, who countered that it's not institutions the future-of-news people have a problem with, but hierarchical institutions, and former Wall Street Journal writer Jason Fry, who said that some forms of news are indeed a commodity. A few others, like Mathew Ingram of GigaOM and Steve Buttry of the Journal Register Co. Cephalexin For Sale, argued that deep reporting vs. new media mastery isn't an either/or proposition, Cephalexin no prescription, pointing to examples of news organizations like the Guardian who do both well.
Former Guardian digital editor Emily Bell also wrote about her old paper's efforts in making a similar point, arguing that the spirit of muckraking is being carried on in these digital, networked initiatives. "The opening of electronic ears and eyes is not a replacement for reporting. It should be at the heart of it. And if it is not, then the institutions that Starkman laments might be to blame," she wrote, Cephalexin For Sale. Starkman responded by arguing that it all boils down to stories, Cephalexin maximum dosage, but the future-of-news folks want to talk about something else, and here at the Lab, C.W. Anderson weighed in on with a smart post on the ways in which institutions can be forces for both good and ill.
A force for digital change in the newsroom: The New York Times announced this week the retirement (effective the end of the year) of one of the pioneers of news on the web — Martin Nisenholtz, a senior vice president at the paper. As the Times noted, Nisenholtz has been intimately involved in just about every major technological initiative the Times has undertaken since he came on board in 1995: Launching the website, moving it into mobile media and tablets, Cephalexin description, and instituting its paywall earlier this year.
Poynter's Julie Moos put together a greatest-hits of commentary Cephalexin For Sale, by and about Nisenholtz over the years, including his prediction in early 2004 that smart phones would be a particularly influential force in changing news delivery. PaidContent's Staci Kramer talked about his lasting impact: No matter how slow (or fast) the transition seemed, "the NYT has an integrated newsroom with an understanding that digital, while it may not always be first, is equal."
Dave Winer, who helped create RSS, pointed out that Nisenholtz made the Times the first major publisher to license its stories for RSS, Cephalexin images, making a significant contribution to the growth of the open web in the process. The Lab's Joshua Benton used that story to illustrate thateven if news orgs can't invent these transformative web tools, they can still play a big role in their evolution and adoption. Media prof C.W. Anderson also noted another contribution Nisenholtz made — by allowing a scholar access to study his paper's digital efforts, he helped revitalize the field of digital media sociology.
A neutral way to tweet: If a few of the most recent sets of social media guidelines are any indication, news organizations are really struggling with the concept of their journalists' retweets on Twitter, Cephalexin For Sale. Several of those organizations have asked journalists not to retweet opinionated content without comment, lest they be thought of as biased themselves. Poynter's Jeff Sonderman tried to resolve that problem with an idea for an NT, Cephalexin from mexico, or neutral tweet, which people could use to retweet something while declaring their neutrality about it.
Most journalism folks on Twitter didn't like the idea, as Sonderman himself showed in his fine roundup of reaction. Many of them saw it as a way to avoid interacting naturally on Twitter, a "pacifier" or "high tech milquetoast," in the words of j-profs Jay Rosen and Matt Waite. Cephalexin For Sale, GigaOM's Mathew Ingram expanded on the idea, calling it a solution to the wrong problem. "By pretending that their journalists don’t have opinions, when everyone knows that they do, mainstream media outlets are suggesting their viewers or readers are too stupid to figure out where the truth lies," he wrote. Buy no prescription Cephalexin online, —
Reading roundup: Lots of smaller stories and discussions popping in and out of the future-of-news world this week. Here's a few of them:
— This week in News Corp. scandal: Rupert Murdoch's son, James, told British Parliament he didn't mislead them last time he talked to them. Or, as Gawker put it, he asserted that everyone's a liar except him. The Guardian's Roy Greenslade doesn't believe him, Cephalexin For Sale. Murdoch also said the company might still close its British newspaper, Cephalexin canada, mexico, india, the Sun. And we also found out News of the World hired people to spy on their hacking victims' lawyers. Guardian editor Alan Rusbridger put the scandal in perspective in a lecture.
— New York Times media critic David Carr mused on the decline of WikiLeaks as an organization and its implications for radical transparency as a movement. Dave Winer and Mathew Ingram responded by questioning why the Times hasn't supported WikiLeaks more itself.
— Andy Rooney of CBS' 60 Minutes, one of the icons of American broadcast television, died late last week at age 92. Cephalexin recreational, You can check out the obituaries from CBS and the New York Times, a set of his classic essays at Gawker, and a thoughtful remembrance by tech entrepreneur Anil Dash.
Similar posts: Armour For Sale. Buy Glucophage No Prescription. Tramadol No Rx. Cipro pictures. Tramadol pharmacy. Buy cheap Armour no rx.
Trackbacks from: Cephalexin For Sale. Cephalexin For Sale. Cephalexin For Sale. Purchase Cephalexin online. Real brand Cephalexin online. About Cephalexin.